Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors

被引:430
作者
Sumie, Shuji [2 ]
Kuromatsu, Ryoko [2 ]
Okuda, Koji [1 ]
Ando, Eiji [2 ]
Takata, Akio [2 ]
Fukushima, Nobuyoshi [2 ]
Watanabe, Yasutomo [2 ]
Kojiro, Masamichi [3 ]
Sata, Michio [2 ]
机构
[1] Kurume Univ, Sch Med, Div Hepato Biliary Pancreat Surg, Fukuoka 8300011, Japan
[2] Kurume Univ, Sch Med, Dept Med, Div Gastroenterol, Fukuoka 8300011, Japan
[3] Kurume Univ, Sch Med, Dept Pathol, Fukuoka 8300011, Japan
关键词
hepatocellular carcinoma; microvascular invasion; gross classification; hepatic resection; recurrence; survival;
D O I
10.1245/s10434-008-9846-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Macroscopic vascular invasion is known to be a poor prognostic factor in hepatocellular carcinoma (HCC). The aim of this study was to determine the outcomes and predictive factors after hepatic resection for HCC with microvascular invasion (MVI). Methods: One hundred ten patients who underwent curative resection for HCC without macroscopic vascular invasion were included in this retrospective study. The risk factors of these patients for recurrence-free and disease-specific survival were investigated, and the clinicopathological factors predicting the presence of MVI were also determined. Results: Of the 110 resected specimens, 49 (45%) had evidence of MVI. By univariate analysis, MVI was found to be statistically significantly associated with greater tumor size, gross classification, histological grade, and intrahepatic micrometastasis. Gross classification proved to be the only independent predictive factor for MVI by multiple logistic regression analysis. By multivariate analysis, cirrhosis and MVI were identified as independent risk factors for recurrence-free survival. The 5-year recurrence-free survival rates for patients with and without MVI were 20.8% and 52.6%, respectively. By multivariate analysis, the number of tumors, presence of MVI, and intrahepatic micrometastasis were identified as independent predictors of disease-specific survival. The 5-year disease-specific survival rates for patients with and without MVI were 59.3% and 92.0%, respectively. Conclusions: The presence of MVI was the most important risk factor affecting recurrence and survival in HCC patients after curative resection. Furthermore, this study showed that gross classification of HCC can be very helpful in predicting the presence of MVI.
引用
收藏
页码:1375 / 1382
页数:8
相关论文
共 38 条
[1]  
Adachi E, 1996, CANCER, V77, P2022, DOI 10.1002/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO
[2]  
2-S
[3]  
[Anonymous], 1990, ANN SURG, V211, P277
[4]   Predictors and patterns of recurrence after resection of hepatocellular carcinoma [J].
Cha, C ;
Fong, YM ;
Jarnagin, WR ;
Blumgart, LH ;
DeMatteo, RP .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 197 (05) :753-758
[5]   ADENOMATOUS HYPERPLASIA IN THE VICINITY OF SMALL HEPATOCELLULAR-CARCINOMA [J].
EGUCHI, A ;
NAKASHIMA, O ;
OKUDAIRA, S ;
SUGIHARA, S ;
KOJIRO, M .
HEPATOLOGY, 1992, 15 (05) :843-848
[6]   Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation [J].
Esnaola, NF ;
Lauwers, GY ;
Mirza, NQ ;
Nagorney, DM ;
Doherty, D ;
Ikai, I ;
Yamaoka, Y ;
Regimbeau, JM ;
Belghiti, J ;
Curley, SA ;
Ellis, LM ;
Vauthey, JN .
JOURNAL OF GASTROINTESTINAL SURGERY, 2002, 6 (02) :224-232
[7]  
Hanazaki K, 2000, HEPATO-GASTROENTEROL, V47, P204
[8]   HEPATIC RESECTION IS NOT ENOUGH FOR HEPATOCELLULAR-CARCINOMA - A FOLLOW-UP-STUDY OF 92 PATIENTS [J].
HARADA, T ;
SHIGEMURA, T ;
KODAMA, S ;
HIGUCHI, T ;
IKEDA, S ;
OKAZAKI, M .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1992, 14 (03) :245-250
[9]   Risk factors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy [J].
Imamura, H ;
Matsuyama, Y ;
Tanaka, E ;
Ohkubo, T ;
Hasegawa, K ;
Miyagawa, S ;
Sugawara, Y ;
Minagawa, M ;
Takayama, T ;
Kawasaki, S ;
Makuuchi, M .
JOURNAL OF HEPATOLOGY, 2003, 38 (02) :200-207
[10]   PROGNOSTIC FACTORS OF HEPATOCELLULAR-CARCINOMA IN PATIENTS UNDERGOING HEPATIC RESECTION [J].
IZUMI, R ;
SHIMIZU, K ;
II, T ;
YAGI, M ;
MATSUI, O ;
NONOMURA, A ;
MIYAZAKI, I .
GASTROENTEROLOGY, 1994, 106 (03) :720-727